semaglutide cardiovascular outcomes news today Effects of on Heart Failure in Diabetes and Chronic Kidney Disease in the FLOW Trial Oral Semaglutide and Cardiovascular Outcomes

Transition Planning from the Beginning Weight regain after stopping GLP-1 medications is real

Non-Surgical Options Loose skin after semaglutide weight loss

They work by: reducing appetite increasing feelings of fullness improving blood sugar regulation Because theyre FDA-approved, clinicians have a much clearer understanding of appropriate dosing, common side effects, and long-term safety compared to investigational drugs like retatrutide

Over time, many people find that enjoyment returns gradually as they develop new eating habits and routines

This first wave of GLP-1s were commercially successful (Victoza saw peak sales of ~$3.8B in 2018), but results were modest relative to todays market